SHELL ASSET MANAGEMENT CO - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 186 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2019. The put-call ratio across all filers is 0.14 and the average weighting 0.9%.

Quarter-by-quarter ownership
SHELL ASSET MANAGEMENT CO ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$281,000
-17.8%
1,862
-20.7%
0.01%
+10.0%
Q2 2022$342,000
+23.0%
2,348
+0.2%
0.01%
+42.9%
Q1 2022$278,000
-25.1%
2,344
-12.9%
0.01%
-12.5%
Q4 2021$371,0000.0%2,690
+0.7%
0.01%0.0%
Q3 2021$371,000
+37.4%
2,671
-4.0%
0.01%
+60.0%
Q2 2021$270,000
+50.0%
2,781
+5.7%
0.01%
+25.0%
Q1 2021$180,000
-54.5%
2,631
-43.1%
0.00%
-50.0%
Q4 2020$396,000
+31.6%
4,6230.0%0.01%
+14.3%
Q3 2020$301,000
-10.9%
4,6230.0%0.01%
-12.5%
Q2 2020$338,000
+111.2%
4,623
-1.8%
0.01%
+100.0%
Q1 2020$160,000
-38.5%
4,706
-1.5%
0.00%
-33.3%
Q4 2019$260,000
+26.8%
4,777
-2.7%
0.01%
+20.0%
Q3 2019$205,000
-5.5%
4,911
-0.8%
0.01%0.0%
Q2 2019$217,000
-16.9%
4,953
-2.2%
0.01%
-16.7%
Q1 2019$261,000
+39.6%
5,0650.0%0.01%
+20.0%
Q4 2018$187,000
-8.8%
5,065
-7.3%
0.01%
+25.0%
Q3 2018$205,0005,4650.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q3 2019
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 900,844$136,181,00079.57%
RP Management, LLC 1,111,111$167,967,00077.60%
JET CAPITAL INVESTORS L P 1,707,500$258,942,00053.95%
Alpine Global Management, LLC 373,999$56,537,00013.23%
Chicago Capital Management, LLC 154,585$23,443,00012.75%
FIFTH LANE CAPITAL, LP 140,000$21,164,00011.03%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 3,784,482$572,100,000,00010.85%
Eversept Partners, LP 637,139$96,316,3038.35%
EQUITEC PROPRIETARY MARKETS, LLC 187,100$28,284,0007.45%
HARVEST MANAGEMENT LLC 48,503$7,332,0005.92%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders